Influence of obesity and body fat distribution on growth hormone kinetics in humans

American Journal of Physiology - Endocrinology and Metabolism

Volumn 277, Issue 5 40-5, 1999, Pages

  Langendonk, Janneke G ^a   Meinders, A Edo ^a   Burggraaf, Jacobus ^a   Frölich, Marijke ^a   Roelen, Corné A M ^b   Schoemaker, Rik C ^a   Cohen, Adam F ^a   Pijl, Hanno ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Clearance; Distribution volume; Fat distribution; Fat mass; Somatotropin

Indexed keywords

GROWTH HORMONE; HUMAN GROWTH HORMONE; SOMATOSTATIN;

ARTICLE; BODY FAT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUOROMETRY; HALF LIFE TIME; HUMAN; KINETICS; OBESITY; PRIORITY JOURNAL;

EID: 0032739365     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1999.277.5.e824     Document Type: Article

References (42)

1. Andersson, B. L., P. Bjorntorp, J. C. Seidell, P. Marin, M. Cigolini, L. Lapidus, J. Svedberg, L. Balabanski, and M. Bialkowska. Measuring Obesity-Classification and Description of Anthropometric Data. Report on a WHO Consultation on Epidemiology of Obesity. Copenhagen: Nutrition Unit, World Health Organization Regional Office for Europe, 1988, p. 1-22.
2. Baumann, G., K. Amburn, and T. A. Buchanan. The effect of circulating growth hormone-binding protein on metabolic clearance, distribution, and degradation of human growth hormone. J. Clin. Endocrinol. Metab. 64: 657-660, 1987.
3. Baumann, G., J. G. MacGart, and K. Amburn. The molecular nature of circulating growth hormone in normal and acromegalic man: evidence for a principle and minor monomeric forms. J. Clin. Endocrinol. Metab. 56: 946-952, 1983.
4. Baumann, G., and M. Mercado. Growth hormone-binding proteins in plasma. Nutrition 9: 546-553, 1993.
5. Baumann, G., and M. A. Shaw. A second, lower affinity growth hormone-binding protein in human plasma. J. Clin. Endocrinol. Metab. 70: 680-686, 1990.
6. Baumann, G., M. W. Stolar, K. Amburn, C. P. Barsano, and B. C. Devries. A specific growth hormone binding protein in human plasma: initial characterization. J. Clin. Endocrinol. Metab. 62: 134-141, 1986.
7. Beauville, M., I. Harant, F. Crampes, D. Riviere, M. T. Tauber, J. P. Tauber, and M. Garrigues. Effect of long term rhGH administration in GH-deficient adults on fat cell epinephrine response. Am. J. Physiol. 263 (Endocrinol. Metab. 26): E467-E472, 1992.
8. Bjorntorp, P. Body fat distribution, insulin resistance, and metabolic diseases. Nutrition 13: 795-803, 1997.
9. Blouin, R. A., J. H. Kolpek, and H. J. Mann. Influence of obesity on drug disposition. Clin. Pharmacol. 6: 706-714, 1987.
10. Bullier-Picard, F., M. C. Postel-Vinay, and C. Kayser. In-vivo uptake of human growth hormone in male rat liver. J. Endocrinol. 121: 19-25, 1989.
11. Calabresi, E., E. Ishikawa, L. Bartolini, G. Delitala, G. Fanciulli, O. Oliva, J. D. Veldhuis, and M. Serio. Somatostatin infusion suppresses GH secretory burst frequency and mass in normal men. Am. J. Physiol. 270 (Endocrinol. Metab. 33): E975-E979, 1996.
12. Corpas, E., S. M. Harman, M. A. Pineyro, R. Roberson, and M. R. Blackman. Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men. J. Clin. Endocrinol. Metab. 75: 530-535, 1992.
13. Cuneo, R. C., F. Salomon, C. M. Wiles, R. Hesp, and P. H. Sonksen. Growth hormone treatment in growth hormone-deficient adults. I. Effects on muscle mass and strength. J. Appl. Physiol. 70: 688-694, 1991.
14. De Boer, H., G. J. Blok, and E. A. van der Veen. Clinical aspects of growth hormone deficiency in adults. Endocr. Rev. 16: 63-86, 1995.
15. Dubey, A. K., A. Hanukoglu, B. C. Hansen, and A. A. Kowarski. Metabolic clearance rates of synthetic human growth hormone in lean and obese male rhesus monkeys. J. Clin. Endocrinol. Metab. 67: 1064-1067, 1988.
16. Faria, A. C., J. D. Veldhuis, M. O. Thorner, and M. L. Vance. Half-time of endogenous growth hormone (GH) disappearance in normal man after stimulation of GH secretion by GH-releasing hormone and suppression with somatostatin. J. Clin. Endocrinol. Metab. 68: 535-541, 1989.
17. Fisker, S., N. Vahl, J. O. L. Jorgensen, J. S. Christiansen, and H. Orskov. Abdominal fat determines growth hormone-binding protein levels in healthy nonobese adults. J. Clin. Endocrinol. Metab. 82: 123-128, 1997.
18. Haffner, D., F. Schaefer, J. Girard, E. Ritz, and O. Mehis. Metabolic clearance of recombinant human growth hormone in health and chronic renal failure. J. Clin. Invest. 93: 1163-1171, 1994.
19. Hall, J. E. Renal and cardiovascular mechanisms of hypertension in obesity. Hypertension 23: 381-394, 1994.
20. Herington, A. C., S. I. Ymer, and J. L. Stevenson. Identification and characterization of specific binding proteins for growth hormone in normal human sera. J. Clin. Invest. 77: 1817-1823, 1986.
21. Hochberg, Z., P. Hertz, V. Colin, S. Ish-Shalom, D. Yeshurun, M. B. Youdim, and T. Amit. The distal axis of growth hormone (GH) in nutritional disorders: GH-binding protein, insulin-like growth factor-I (IGF-I), and IGF-I receptors in obesity and anorexia nervosa. Metabolism 41: 106-112, 1992.
22. Hortobagyi, T., R. G. Israel, and K. F. O'Brien. Sensitivity and specificity of the Quetelet index to assess obesity in men and women. Eur. J. Clin. Nutr. 48: 369-375, 1994.
23. Husman, B., J. A. Gustafson, and G. Andersson. Receptor-mediated endocytosis and degradation of bovine growth hormone in rat liver. Mol. Cell. Endocrinol. 59: 13-25, 1988.
24. Iranmanesh, A., G. Lizarralde, and J. D. Veldhuis. Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. J. Clin. Endocrinol. Metab. 73: 1081-1088, 1991.
25. Lee, E. J., K. R. Kim, K. M. Lee, S. K. Lim, H. C. Lee, J. H. Lee, D. J. Lee, and K. B. Huh. Reduced growth hormone response to L-dopa and pyridostigmine in obesity. Int. J. Obes. 18: 465-468, 1994.
26. Lukaski, H. C. Methods for the assessment of human body composition: traditional and new. Am. J. Clin. Nutr. 46: 537-556, 1987.
27. Postel-Vinay, M. C., C. Saab, and M. Gourmelen. Nutritional status and growth hormone-binding protein. Horm. Res. 44: 177-181, 1995.
28. Rabkin, R., T. I. Gottheiner, and V. S. Fang. Removal and excretion of immunoreactive rat growth hormone by the isolated kidney. Am. J. Physiol. 240 (Renal Fluid Electrolyte Physiol. 9): F282-F287, 1981.
29. Rasmussen, M. H., K. K. Ho, L. L. Kjems, and J. Hilsted. Serum growth hormone-binding protein in obesity: effect of a short-term, very low calorie diet and diet induced weight loss. J. Clin. Endocrinol. Metab. 81: 1519-1524, 1996.
30. Rasmussen, M. H., A. Hvidberg, A. Anders, K. M. Main, A. Gotfredsen, N. E. Skakkebaek, and J. Hilsted. Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects. J. Clin. Endocrinol. Metab. 80: 1407-1415, 1995.
31. Roelen, C. A. M., G. H. Donker, J. H. H. Thijssen, and M. A. Blankenstein. A method for measuring binding affinity and capacity of growth hormone binding protein in human serum using FPLC to separate bound and free ligand. J. Liq. Chromatog. 15: 1259-1275, 1992.
32. Roelen, C. A., H. P. Koppeschaar, W. R. De Vries, Y. E. Snel, M. E. Doerga, P. M. Zelissen, J. H. Thijssen, and M. A. Blankenstein. Visceral adipose tissue is associated with circulating high affinity growth hormone-binding protein. J. Clin. Endocrinol. Metab. 81: 760-764, 1997.
33. Roubenoff, R. Applications of bioelectrical impedance analysis for body composition to epidemiologic studies. Am. J. Clin. Nutr. 64, Suppl: 459S-462S, 1996.
34. Roubenoff, R., G. E. Dallal, and P. W. Wilson. Predicting body fatness: the body mass index vs. estimation by bioelectrical impedance. Am. J. Public Health 85: 726-728, 1995.
35. Roupas, P., and A. C. Herington. Processing of growth hormone by rat adipocytes in primary culture: differentiation between release of intact hormone and degradative processing. Endocrinology 121: 1521-1530, 1987.
36. Rudling, M., G. Norstedt, H. Olivecrona, E. Reihner, J. A. Gustafsson, and B. Angelin. Importance of growth hormone for the induction of hepatic low density lipoprotein receptors. Proc. Natl. Acad. Sci. USA 89: 6983-6987, 1992.
37. Salomon, F., R. C. Cuneo, R. Hesp, and P. H. Sonksen. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N. Engl. J. Med. 321: 1797-1803, 1989.
38. Schaefer, F., G. Baumann, D. Haffner, L. M. Faunt, M. L. Johnson, M. Mercado, E. Ritz, O. Mehls, and J. D. Veldhuis. Multifactorial control of the elimination kinetics of unbound (free) growth hormone (GH) in the human: regulation by age, adiposity, renal function, and steady state concentrations of GH in plasma. J. Clin. Endocrinol. Metab. 81: 22-31, 1996.
39. Sonnenberg, G. E., U. Keller, A. Perruchoud, A. Burkhardt, and K. Gyr. Effect of somatostatin on splanchnic hemodynamics in patients with cirrhosis of the liver and in normal subjects. Gastroenterology 80: 526-532, 1981.
40. Vahl, N., J. O. L. Jørgensen, C. Skjærbæk, J. D. Veldhuis, H. Orskov, and J. S. Christiansen. Abdominal adiposity rather than age and sex predicts mass and regularity of GH secretion in healthy adults. Am. J. Physiol. 272 (Endocrinol. Metab. 35): E1108-E1116, 1997.
41. Veldhuis, J. D., A. Iranmanesh, K. K. Ho, M. J. Waters, M. L. Johnson, and G. Lizarralde. Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man. J. Clin. Endocrinol. Metab. 72: 51-59, 1991.
42. Veldhuis, J. D., M. L. Johnson, L. M. Faunt, M. Mercado, and G. Baumann. Influence of the high-affinity growth hormone (GH)-binding protein on plasma profiles of free and bound GH and on the apparent half-life of GH. J. Clin. Invest. 91: 629-641, 1993.